Physician profile
Michael E Schoeffler
NPI 1912994880
$4,027.32
in general payments reported to CMS, 2019-2025
15 companies · $359 in 2025
The $359 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $501 · 2020: $485 · 2021: $203 · 2022: $888 · 2023: $842 · 2024: $750 · 2025: $359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,818 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $122 · Education: $10.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,817.55 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $122.34 |
| Education | $10.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,007.20 | 2020-2024 | Repatha |
| Merck Sharp & Dohme LLC | $590.57 | 2021-2025 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $393.08 | 2019-2025 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $336.23 | 2019-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $332.87 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $215.60 | 2019-2025 | |
| Amarin Pharma, INC. | $204.84 | 2020-2022 | |
| Regeneron Healthcare Solutions, INC. | $191.22 | 2022-2024 | Evkeeza |
| Abbott Laboratories | $169.16 | 2023 | Cardiomems, Mitraclip |
| Kowa Pharmaceuticals America, INC. | $156.45 | 2019-2021 | |
| Pfizer INC. | $152.34 | 2025 | |
| Medicure Pharma INC. | $122.34 | 2024 | Zypitamag |
| Althera Pharmaceuticals LLC | $105.00 | 2022 | |
| Esperion Therapeutics, INC. | $28.14 | 2020-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.28 | 2024 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Schoeffler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.